China’s WuXi AppTec Invests In US Biotech Software Firm Backed By Bill Gates

Violet Tang
January 7, 2019 — 15:16 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: America Bill Gates biotech China chinese Expansion Gates Foundation Google investment Melinda Gates Microsoft New York pharmaceutical Qiming Venture Partners Schrödinger search engine Seattle software technology The Bill and Melinda Gates Foundation Trust Washington WuXI AppTec

Related News:

Chinese AI Unicorn Zhipu AI Secures Major Funding Amid Competitive Landscape

September 19, 2024 — 01:18

ByteDance Expands AI Hardware Ambitions with Smart Headphones, AI Glasses, and More

September 14, 2024 — 01:59

Zhipu AI Unveils New Products and Announces Further Price Cuts as GenAI Price Wars Deepen in China

June 7, 2024 — 00:11

ByteDance Eyes AI Hardware, Exploring Wearable Earphones and Handheld AI Devices, Inspired by Microsoft’s Ecosystem Strategy

May 30, 2024 — 07:34

ByteDance’s Generative AI Play: Innovations vs. Pricing Wars – Will the App-Centric Strategy Prevail in the AI Era?

May 21, 2024 — 02:52

Decoding China’s Top Ten Generative AI Models: Established Tech Old Guards Lead the Charge in the GenAI Era

May 16, 2024 — 01:59

Hong Kong’s Bitcoin and Ethereum Spot ETFs Suffer Disappointing Debut, Yet Hope for Future Growth Persists

April 30, 2024 — 23:36

ByteDance’s Pragmatic AI Strategy: A Factor in Its Lag Behind OpenAI and Its Approach to Catching Up

April 24, 2024 — 00:28

Hong Kong Approves Spot Bitcoin and Ethereum ETFs, Enabling In-Kind Redemptions and Anticipated to Energize Local Crypto Market

April 16, 2024 — 03:57

Franchising and Licensing Asia (FLAsia) 2024